Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EB-001 for Musculoskeletal Pain in Breast Augmentation
NCT03193593Phase 2Completed
- Sponsor
- Bonti
- Start
- Aug 2017
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands, Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of trenibotulinumtoxinE in postoperative pain (7 arms), sponsored by Bonti. Primary endpoint: Subject's Assessment of Pain Using the Numeric Pain Rating Scale (AUC16h-96h). Started Aug 2017; status: completed.
02
Drugs
trenibotulinumtoxinE
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03193593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03193593.